Lead party: E Squared Investments (Pty) Ltd (investor/buyer)
Coverage: Meridian Capital (investment and transaction tracker; data from Partner Researchers, editorially reviewed).
Target: Altera Biosciences Inc. (private company) · Sector: Healthcare, Biotechnology · Countries of operation: South Africa
Transaction type: Investment · Asset class: Venture Capital · Strategy: Venture Equity · Instrument: Equity · Round: Pre-Seed · Deal amount: US$1.6m
Investors/buyers: E Squared Investments (Pty) Ltd, OneBio Venture Studio
Legal advisers: not identified in the source record.
Source: announced 29 July 2025. Original announcement: linkedin.com.


